Literature DB >> 4988941

Fluorescein angiography in experimental ocular hypertension.

I Swietliczko, N J David.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4988941     DOI： 10.1016/0002-9394(70)90094-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  8 in total

1.  Effect of acute intraocular pressure changes on short posterior ciliary artery haemodynamics.

Authors:  K M Joos; M D Kay; L E Pillunat; A Harris; E K Gendron; W J Feuer; B E Steinwand
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

2.  Fluorescein angiography: its contributions towards understanding the mechanisms of visual loss in glaucoma.

Authors:  G L Spaeth
Journal:  Trans Am Ophthalmol Soc       Date:  1975

3.  The role of lipid dysregulation and vascular risk factors in glaucomatous retrobulbar circulation.

Authors:  Monika Modrzejewska; Wilhelm Grzesiak; Daniel Zaborski; Anna Modrzejewska
Journal:  Bosn J Basic Med Sci       Date:  2015-03-15       Impact factor: 3.363

4.  Effect of changes in intraocular pressure on the retinal microcirculation.

Authors:  T J Ffytche; C J Bulpitt; E M Kohner; D Archer; C T Dollery
Journal:  Br J Ophthalmol       Date:  1974-05       Impact factor: 4.638

5.  Electroretinal responses in ocular vascular occlusions due to temporal arteritis.

Authors:  D McLeod
Journal:  Br J Ophthalmol       Date:  1973-12       Impact factor: 4.638

6.  Fluorescein angiography during induced ocular hypertension in glaucoma.

Authors:  M Best; M Blumenthal; M A Galin; H Toyofuku
Journal:  Br J Ophthalmol       Date:  1972-01       Impact factor: 4.638

7.  Fluorescein angiography of the choroid in health and disease.

Authors:  J J De Laey
Journal:  Int Ophthalmol       Date:  1983-02       Impact factor: 2.031

8.  Clinicopathological correlation of parapapillary atrophy in monkeys with experimental glaucoma and temporary central retinal artery occlusion.

Authors:  Jost B Jonas; Sohan S Hayreh; Yong Tao
Journal:  Indian J Ophthalmol       Date:  2014-02       Impact factor: 1.848
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.